Pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis: pharmacokinetics and preliminary safety in a macaque model
June 2014
Click for full info +Pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis: pharmacokinetics and preliminary safety in a macaque model
| | 16 June 2014 |
In this Journal Article:
Health Risk(s):HIV
Product Type(s):IVR (Intravaginal Rings)
Full Info:
Resource Type:
Citation:
Moss, J. A., Srinivasan, P., Smith, T. J., Butkyavichene, I., Lopez, G., Brooks, A. A., … & Baum, M. M. (2014, June 16). Antimicrobial Agents and Chemotherapy, AAC-02871.
Authors:
Moss, J. A., Srinivasan, P., Smith, T. J., Butkyavichene, I., Lopez, G., Brooks, A. A., ... & Baum, M. M.
Health Risks(s):
- HIV
Product type(s):
- IVR
Topic(s):
URL of resource:
http://aac.asm.org/content/early/2014/06/11/AAC.02871-14.short